The Bull Rankings scorecard — our quality-growth score is 80.6 / 100, built from three pillars scored 0–100: Quality 85, Growth 93, Value 67 (valuation is judged against sector peers). At today's price, our reverse-DCF read says the market is implicitly betting on free-cash-flow growth of about 12% a year next year, fading to 4% a year by year ten — a gauge of how much optimism is already in the stock.
The thesis
The Vita Coco Company is priced for a moderate upside that hinges on its growth engine and the durability of its free‑cash‑flow returns. Three figures anchor the case: a 26.1 % revenue growth in the trailing twelve months, a free‑cash‑flow of $124 m that has been rising, and a profit margin of 15.5 % that outpaces most peers in the non‑alcoholic beverage space. Our model’s quality‑growth score of 80.6 reflects a company that is already generating solid returns and has a clear path to compound those returns. The strongest pillar—Growth (93)—is the engine that justifies the current valuation, while the weakest pillar—Value (67)—shows the stock is still reasonably priced relative to sector peers. The price does not yet demand a premium for future growth, so the upside is not a bubble but a reasonable expectation of continued expansion.
What the business actually is
Vita Coco sells coconut‑based beverages and related products under a single, globally recognized brand. Its core line is coconut water, distributed through club, food, drug, mass, convenience, e‑commerce, and foodservice channels across the United States, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company also offers Vita Coco Treats, a plant‑based dairy alternative, Vita Coco Pressed and Vita Coco Coconut Juice, and the PWR LIFT protein‑infused fitness drink. Private‑label manufacturing for retailers adds a steady revenue stream. The breadth of product categories keeps the brand relevant to health‑conscious consumers and allows cross‑selling across channels.
Why it can (and does) keep compounding
The moat is built on brand equity and distribution breadth. With a 15.5 % profit margin and a ROE of 27.3 %, the company turns revenue into cash efficiently. The debt‑to‑equity of 0.04 signals a near‑zero leverage burden, freeing management to invest in growth without risking solvency. The beta of 0.75 indicates lower volatility than the market, suggesting that the business is less sensitive to macro swings. Our model’s “Durable high returns” signal confirms that the company’s free‑cash‑flow yield is sustainable; the free‑cash‑flow of $124 m in the trailing twelve months is a tangible measure of that durability. Competitors cannot replicate the brand’s global reach or its deep penetration into the health‑drink segment without significant time and capital.
The valuation question
The current P/E of 30.9 sits above the Consumer Defensive median (≈75th percentile), implying the market is already pricing in a premium for growth. The reverse‑DCF shows that today’s price assumes a free‑cash‑flow growth of about 12 % in year 1 that tapers to 4 % by year 10. This starting rate is lower than the trailing revenue growth of 26.1 %, meaning the market is pricing in a modest slowdown. In other words, the stock already carries a pessimistic bias relative to the recent performance; if the company can sustain its 26 % revenue growth for several quarters, the implied growth rate will be too low, and the price will be undervalued. The Value score of 67 confirms that the stock is still on the cheaper side of its sector peers, reinforcing the notion that the market has not yet fully priced in the company’s growth trajectory.
The bear case
The most credible risk is that growth stalls. If revenue growth falls below 20 %—the threshold that would push the reverse‑DCF implied growth below the 12 % starting point—the stock’s valuation would contract sharply. A decline in the profit margin below 12 % would erode free‑cash‑flow and hurt the durable‑returns signal. The weakest pillar, Value (67), reminds us that the market still sees room for improvement; if the stock’s price climbs to the 75th percentile of the sector, the Value score would deteriorate, signaling over‑valuation. A sustained drop in free‑cash‑flow or an uptick in debt would also erode the company’s financial flexibility.
What would change our mind
- Revenue growth slipping below 20 % for two consecutive quarters would invalidate the growth‑centric thesis.
- Profit margin falling under 12 % would undermine the durable‑returns signal and push the Value score toward the 50‑point range.
- Free‑cash‑flow turning negative or a debt‑to‑equity rise above 0.10 would signal financial distress and erode the moat.
If any of these thresholds are breached, the current upside narrative collapses, and the stock would need to be re‑evaluated as a value play rather than a growth play.